Sign Up to like & get recommendations! 1
Published in 2019 at "American Journal of Clinical Dermatology"
DOI: 10.1007/s40257-018-00419-1
Abstract: BackgroundConcerns have been raised that propranolol treatment of infantile hemangioma (IH) may be associated with increased risks of adverse effects and growth impairment in preterm infants due to their immature development.ObjectiveThis study aimed to find… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Pediatric Research"
DOI: 10.1038/pr.2017.220
Abstract: BackgroundPropranolol is the first-choice treatment for severe infantile hemangioma (IH). However, 10– 30% of lesions relapse after propranolol treatment. The mechanisms underlying IH recurrence after propranolol treatment have not been completely elucidated.MethodsThis study combined an… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/srep43292
Abstract: There is no definitive conclusion regarding the optimal timing for terminating propranolol treatment for infantile hemangioma (IH). A total of 149 patients who underwent detailed color Doppler ultrasound examination were included in this study. The… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "PAIN"
DOI: 10.1097/j.pain.0000000000001007
Abstract: Abstract Migraine is currently conceptualized as a chronic disease with episodic manifestations. In some patients, migraine attack frequency increases, leading to chronic migraine. Daily preventive therapy is initiated to decrease attack frequency. Propranolol, a first-line… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17925
Abstract: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. IHs follow a typical course: they appear within few days to weeks after birth and usually grow rapidly during the first year of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Paediatrics and Child Health"
DOI: 10.1111/jpc.14375
Abstract: The aim of this study was to assess the efficacy of propranolol treatment in multifocal and diffuse infantile hepatic haemangioma (IHH). read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-313273.18
Abstract: Background and aims Infantile hemangioma is a benign vascular tumour of infancy, affecting with a higher incidence the premature infants and females. It is not possible to predict the final size of infantile hemangioma, or… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Indian Association of Pediatric Surgeons"
DOI: 10.4103/jiaps.jiaps_232_19
Abstract: Arteriovenous malformations (AVMs) of the scrotum are very rare, with only 35 adult cases in the literature. An 8-year-old boy presented with an ulcerated bleeding AVM of the scrotum. The patient was resuscitated and managed… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Indian Association of Pediatric Surgeons"
DOI: 10.4103/jiaps.jiaps_3_21
Abstract: Background: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. Propranolol is considered first-line therapy for IH. However, it is associated with side effects. Therefore, there was a need for alternative therapy.… read more here.